NB
CRL icon

Norinchukin Bank’s Charles River Laboratories CRL Stock Holding History

Norinchukin Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Sell
2,803
-10
-0.4% -$1.78K 0.01% 508
2026
Q1 		$485K Buy
2,813
+2
+0.1% +$371 0.01% 515
2025
Q4 		$561K Buy
2,811
+159
+6% +$28.8K 0.01% 512
2025
Q3 		$415K Sell
2,652
-48
-2% -$7.62K 0.01% 524
2025
Q2 		$410K Buy
2,700
+146
+6% +$19.5K 0.01% 526
2025
Q1 		$384K Buy
2,554
+299
+13% +$50.1K 0.01% 520
2024
Q4 		$416K Buy
2,255
+167
+8% +$32.2K 0.01% 496
2024
Q3 		$411K Buy
2,088
+283
+16% +$58.8K 0.01% 492
2024
Q2 		$373K Buy
1,805
+110
+6% +$24.9K 0.01% 476
2024
Q1 		$459K Sell
1,695
-19
-1% -$4.54K 0.01% 453
2023
Q4 		$405K Sell
1,714
-32
-2% -$6.29K 0.01% 467
2023
Q3 		$342K Sell
1,746
-540
-24% -$111K 0.01% 491
2023
Q2 		$481K Sell
2,286
-742
-25% -$148K 0.01% 501
2023
Q1 		$611K Buy
3,028
+102
+3% +$23.1K 0.01% 462
2022
Q4 		$638K Sell
2,926
-544
-16% -$119K 0.01% 440
2022
Q3 		$683K Buy
3,470
+312
+10% +$67.4K 0.01% 438
2022
Q2 		$676K Sell
3,158
-1,454
-32% -$355K 0.01% 439
2022
Q1 		$1.31M Buy
4,612
+422
+10% +$130K 0.02% 412
2021
Q4 		$1.58M Sell
4,190
-14
-0.3% -$5.44K 0.02% 359
2021
Q3 		$1.74M Buy
4,204
+56
+1% +$23.3K 0.02% 328
2021
Q2 		$1.53M Buy
+4,148
New +$1.39M 0.02% 341

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Norinchukin Bank's CRL Position: Q2 2026 in Review

Norinchukin Bank reduced its Charles River Laboratories (CRL) stake by 0.36% in Q2 2026, selling an estimated $1.78K and leaving 2,803 shares worth $636K. The position accounts for 0.01% of the portfolio, ranked #508.

Norinchukin Bank first reported a position in CRL in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.74M in Q3 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Norinchukin Bank held 2,803 shares of Charles River Laboratories worth $636K as of Q2 2026.
  • Norinchukin Bank sold 10 Charles River Laboratories shares in Q2 2026, an estimated $1.78K.
  • Charles River Laboratories made up 0.01% of Norinchukin Bank's portfolio in Q2 2026, its #508 holding.
  • Norinchukin Bank first reported a position in Charles River Laboratories in Q2 2021 and has held it in 21 quarters since.
  • Norinchukin Bank's Charles River Laboratories position peaked at $1.74M in Q3 2021.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.